|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01355 BIOSYSEN
Nominal 
0.170 +0.016 (+10.390%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Turnover | 25,086 | -1.411% | 25,445 | 19,104 | 30,524 | 31,842 |
| Cost of Sales | (13,446) | 59.407% | (8,435) | -- | -- | -- |
| Gross Profit | 11,640 | -31.570% | 17,010 | -- | -- | -- |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,455) | -70.564% | (8,340) | 46 | 247 | (79) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,110) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 52,726 | -- | (14,773) | 1,227 | (7,061) | (13,506) | |
| Taxation | 0 | -- | 0 | (248) | (757) | (830) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (31,577) | -- | 1,289 | 2,232 | 2,470 | 6,801 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 21,149 | -- | (13,484) | 3,211 | (5,348) | (7,535) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/06 HKD(K$) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | |
| Net Finance Costs / (Income) | 2,039 | -20.071% | 2,551 | 3,059 | 3,528 | 4,075 |
| Depreciation & Amortisation | 5,943 | -19.318% | 7,366 | 12,231 | 14,824 | 16,253 |
| Directors' Emoluments | 338 | -2.029% | 345 | 1,189 | 1,189 | 979 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 1.457 | -- | -1.358 | 0.518 | -0.759 | -1.072 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.010) | -- | (0.014) | (0.046479) | (0.005724) | 0.00611 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 21,149 |
| %Change | -- |
| EPS / (LPS) | HKD 0.015 |
| NBV Per Share ($) | HKD -0.010 |